RxSight (RXST) Other Non-Current Liabilities (2020 - 2025)

RxSight (RXST) has reported Other Non-Current Liabilities for 5 consecutive years, with $3.2 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Other Non-Current Liabilities rose 88.24% year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2025 stood at $3.2 million (up 88.24% YoY), and the FY2025 full-year result was $3.2 million, up 88.24% from the prior year.
• Other Non-Current Liabilities climbed to $3.2 million in Q4 2025 per RXST's latest filing, from $1.7 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $3.2 million in Q4 2025 and bottomed at $74000.0 in Q4 2023.
• Historically, Other Non-Current Liabilities has averaged $1.3 million across 4 years, with a median of $888000.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities jumped 2197.3% in 2024, then surged 88.24% in 2025.
• Over 4 years, Other Non-Current Liabilities stood at $2.6 million in 2021, then tumbled by 97.17% to $74000.0 in 2023, then surged by 2197.3% to $1.7 million in 2024, then soared by 88.24% to $3.2 million in 2025.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $3.2 million, $1.7 million, and $74000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.